Inventor

TRZASKA SCOTT

US7 patents

⚠️ This page may combine multiple inventors who share the name “TRZASKA SCOTT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MITOBRIDGE INC

3 patents

US11530192B2Dec 20, 2022

MERCK SHARP & DOHME

2 patents

US10035796B2Jul 31, 2018

Crystalline forms of a BACE inhibitor, compositions, and their use

MERCK SHARP & DOHME2 citations67

US10017505B2Jul 10, 2018

Crystalline forms of a BACE inhibitor, compositions, and their use

MERCK SHARP & DOHME2 citations62

SCHERING CORP

1 patent

US7956189B2Jun 7, 2011

Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methoxy-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore

SCHERING CORP7 citations80

ARALEZ PHARMACEUTICALS TRADING DAC

1 patent

US9604971B2Mar 28, 2017

Co-crystal of the PAR-1 receptor antagonists vorapaxar and aspirin

ARALEZ PHARMACEUTICALS TRADING DAC1 citations36

TRZASKA SCOTT

MITOBRIDGE INC

Crystalline and salt forms of PPAR agonist compounds

Crystalline and salt forms of PPAR agonist compounds

Crystalline and salt forms of PPAR agonist compounds

MERCK SHARP & DOHME

Crystalline forms of a BACE inhibitor, compositions, and their use

Crystalline forms of a BACE inhibitor, compositions, and their use

SCHERING CORP

Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methoxy-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore

ARALEZ PHARMACEUTICALS TRADING DAC

Co-crystal of the PAR-1 receptor antagonists vorapaxar and aspirin